<DOC>
	<DOC>NCT00100113</DOC>
	<brief_summary>The purpose of this study is to assess potential interactions between intravenous (IV) cocaine and 3 doses of GBR 12909.</brief_summary>
	<brief_title>Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1</brief_title>
	<detailed_description>This is Phase 1, double-blind, placebo-controlled human laboratory clinical pharmacology study that will assess the potential interactions between IV cocaine and 3 escalating oral doses of GBR 12909. The primary objective is to determine safety of GBR 12909 administration and if there are significant interactions between GBR 12909 treatment concurrent with IV cocaine infusions.</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Vanoxerine</mesh_term>
	<criteria>Must be within 20% ideal body weight and must weigh at least 45 kg. Must understand the study procedures and provide written informed consent. Must meet DSM4 criteria and are nontreatment seeking at time of study. Please contact study site for more information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2005</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>